Cost Effectiveness Analysis of Critical Care in Resource Limited Setting (CEACCLR)

September 21, 2015 updated by: Hajrunisa Cubro, University of Sarajevo

Cost Effectiveness of Intensive Care in a Low Resource Setting: Prospective Cohort of Medical Critically Ill Patients

The purpose of this study was to examine the cost effectiveness of critical care in a middle income country with limited resources.

The main study hypothesis was that critical care is cost effective in low resources setting.

Study Overview

Detailed Description

The investigators objective was to calculate the cost effectiveness of treatment of critically ill patients in a medical ICU of a middle income country with limited access to ICU resources.

Methods: Consecutive critically ill medical patients treated in a recently established medical ICU in Sarajevo, Bosnia and Herzegovina, were prospectively recorded and a subsequent cost utility analysis of intensive care in comparison to hospital ward treatment from the perspective of health care system was performed. Incremental cost effectiveness was calculated using estimates of ICU versus non-ICU treatment effectiveness based on a formal systematic review of published studies. Decision analytic modeling was used to compare treatment alternatives. Sensitivity analyses of the key model parameters were performed.

Study Type

Observational

Enrollment (Actual)

148

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

consecutive critically ill patients treated during one year in a recently established medical ICU at the Sarajevo University Clinical Center.

Description

Inclusion Criteria:

  • patients treated between June 1 2011 and June 29 2012 in the medical ICU

Exclusion Criteria:

  • Patients who stayed in the ICU less than 24 hours and
  • hospital readmissions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
ICU patients
The actual cohort of 148 critically ill medical patients that received the treatment in the intensive care unit (ICU). The interventions include interventions that are usually performed within the ICU such as mechanical ventilation, non-invasive ventilation, neuromuscular blockade, renal replacement therapy.
ventilator support for the patients presenting with acute respiratory failure
Other Names:
  • ventilator
paralysis of the skeletal muscles in order to optimize mechanical ventilation, especially during ARDS
Other Names:
  • neuromuscular block
the procedures used to treat acute kidney injury
Other Names:
  • continuous hemofiltration (CHF) or hemodiafiltration (CHDF)
Procedure used for ventilation support in patients with congestive heart failure, pulmonary edema, COPD and some other conditions.
Other Names:
  • continuous positive airway pressure (CPAP)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
survival
Time Frame: one year after hospital release
mortality was recorded one year after hospital discharge and subtracted from the value od 100% in order to get one year survival
one year after hospital release

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
mortality
Time Frame: 30 days and 60 days after critical illness onset and one year after hospital release
30 days and 60 days after critical illness onset and one year after hospital release
health related quality of life (HRQOL)
Time Frame: one year after hospital release
HRQOL was assessed using EQ5D-3L questionnaire
one year after hospital release

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hajrunisa Cubro, MD, Medical ICU University of Sarajevo Clinical Center, Sarajevo, Bosnia and Herzegovina
  • Study Chair: Ognjen Gajic, MD, MSc, Division of Pulmonary and Critical Care Mayo Clinic Rochester MN USA

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2011

Primary Completion (Actual)

June 1, 2012

Study Completion (Actual)

June 1, 2013

Study Registration Dates

First Submitted

September 18, 2015

First Submitted That Met QC Criteria

September 21, 2015

First Posted (Estimate)

September 22, 2015

Study Record Updates

Last Update Posted (Estimate)

September 22, 2015

Last Update Submitted That Met QC Criteria

September 21, 2015

Last Verified

September 1, 2015

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critical Illness

Clinical Trials on mechanical ventilation

3
Subscribe